Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 18120
Corporate User License Price USD 750
Corporate User License Price INR 54360
Site License Price USD 500
Site License Price INR 36240
Request a Quote

Report Title

Dr. Reddys Laboratories Ltd (DRREDDY) - Medical Equipment - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Dr. Reddys Laboratories Ltd (DRREDDY) - Medical Equipment - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Dr. Reddys Laboratories Ltd (DRREDDY) - Medical Equipment - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Dr. Reddys Laboratories Ltd (DRREDDY) - Medical Equipment - Deals and Alliances Profile



Executive Summary

Summary

Dr. Reddy's Laboratories Ltd (Dr. Reddy's) is a pharmaceutical company which manufactures and markets generic formulations, active pharmaceutical ingredients, biosimilars and proprietary products. The company's generic products are used for the treatment of conditions such as gastrointestinal disorders, oncology, cardiovascular diseases, pain management, Central Nervous System, cancer, pain, infectious diseases and pediatrics. The company provides more than 150 products. The company also develops generic biosimilar products and has four products in the market. The company also discovers, develops, manufactures and markets New Chemical Entities (NCEs) focusing on bacterial infections, metabolic disorders, pain and inflammation. The company markets products in over 75 countries in the US, Europe, Latin America and Asia. Dr. Reddy's is headquartered in Hyderabad, Telangana, India.

Dr. Reddy's Laboratories Ltd (DRREDDY)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Dr. Reddy's Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deal Details 11

Private Equity 11

Cipla, Zydus Cadilla, Dr. Reddy's Labs and Baring Asia May Acquire Bharat Serums and Vaccines 11

Partnerships 13

Dr. Reddy's Labs and Integra LifeSciences Holdings Enter into Distribution Agreement 13

CytoSorbents Enters into Agreement with Dr. Reddy's Labs 14

Equity Offering 15

Octoplus Completes First Tranche Of Private Placement Of Common Stock For USD 1.6 Million 15

Acquisition 16

Dr Reddy's Labs Acquires OctoPlus 16

Dr. Reddy's Laboratories Ltd-Key Competitors 18

Dr. Reddy's Laboratories Ltd-Key Employees 19

Dr. Reddy's Laboratories Ltd-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 23

Recent Developments 24

Financial Announcements 24

Jul 26, 2018: Dr. Reddy's Q1 FY19 financial results 24

May 22, 2018: Dr. Reddy's Q4 and FY18 Financial Results 26

Jan 25, 2018: Dr. Reddy's Q3 and 9M FY18 Financial Results 28

Oct 31, 2017: Dr. Reddy's Q2 and H1 FY18 Financial Results 30

Jul 27, 2017: Dr. Reddy's Q1 FY18 Financial Results 31

May 12, 2017: Dr. Reddy's Q4 and FY17 Financial Results 32

Feb 04, 2017: Dr. Reddy's Q3 and 9M FY17 Financial Results 34

Corporate Communications 36

Jun 14, 2018: Dr. Reddy's Announces Resignation of Hans Peter Hasler As Independent Director 36

Mar 29, 2018: Dr. Reddy's Laboratories announces Senior Leadership Changes 37

Oct 30, 2017: Dr Reddys Laboratories appoints Prasad R Menon as an Additional Director 38

Legal and Regulatory 39

Aug 23, 2018: Dr. Reddy's Laboratories: Update on audit of API Srikakulam Plant, Andhra Pradesh 39

Jun 28, 2018: Dr. Reddy's Laboratories: Update on Audit of its API Hyderabad Plant 3 and API Hyderabad Plant 1 40

Jun 02, 2018: Dr. Reddy's Laboratories Provides Update on US FDA Inspection of its API Srikakulam Plant 41

Apr 24, 2018: Dr. Reddy's Laboratories Provides Update on US FDA Inspection of its API Plant in Mirfield, UK 42

Feb 25, 2018: Dr. Reddy's Laboratories Provides Update on USFDA Audit of its API Manufacturing Plant at Srikakulam, India 43

Feb 19, 2018: Dr Reddy's Laboratories: Update on US Lawsuit 44

Jan 24, 2018: Dr. Reddy's Laboratories: Intimation regard to Communication from Betapharm Arzneimittel, Germany from the Regulatory Authority of Germany 45

Dec 01, 2017: Dr. Reddy's Laboratories: Intimation regard to the US FDA audit 46

Sep 21, 2017: Dr. Reddy's Laboratories: Intimation about audit of Srikakulam Plant Unit II, Andhra Pradesh, by the US FDA 47

Sep 15, 2017: Dr. Reddy's Laboratories: Intimation about audit of API Mirfield Plant, United Kingdom, by the US FDA 48

Sep 08, 2017: Dr. Reddy's Laboratories: Regulatory Authority of Germany concludes audit of Formulations manufacturing facility in Vishakapatnam, India 49

Sep 08, 2017: Dr. Reddy's Laboratories Announces Intimation on audit 50

Jul 21, 2017: Dr. Reddy's Laboratories: Update On US FDA Audit at API Cuernavaca Plant 51

Jun 16, 2017: Dr. Reddy's Laboratories: Update on USFDA Audit 52

Jun 14, 2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda 53

May 25, 2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant 54

Apr 14, 2017: Dr. Reddy's Provides Update on USFDA Audit 55

Apr 03, 2017: Dr. Reddy's Laboratories Provides Update on USFDA Inspection at Srikakulam plant 56

Feb 21, 2017: Dr. Reddy's Laboratories Announces US FDA Inspection on Miryalaguda Facility 57

Other Significant Developments 58

Feb 08, 2017: Dr. Reddy's Expands Commercial Operations in Europe 58

Appendix 59

Methodology 59

About GlobalData 59

Contact Us 59

Disclaimer 59

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

Dr. Reddy's Laboratories Ltd, Medical Equipment, Key Facts, 2018 2

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Dr. Reddy's Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Dr. Reddy's Laboratories Ltd, Deals By Market, 2012 to YTD 2018 9

Dr. Reddy's Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Cipla, Zydus Cadilla, Dr. Reddy's Labs and Baring Asia May Acquire Bharat Serums and Vaccines 11

Dr. Reddy's Labs and Integra LifeSciences Holdings Enter into Distribution Agreement 13

CytoSorbents Enters into Agreement with Dr. Reddy's Labs 14

Octoplus Completes First Tranche Of Private Placement Of Common Stock For USD 1.6 Million 15

Dr Reddy's Labs Acquires OctoPlus 16

Dr. Reddy's Laboratories Ltd, Key Competitors 18

Dr. Reddy's Laboratories Ltd, Key Employees 19

Dr. Reddy's Laboratories Ltd, Subsidiaries 20

Dr. Reddy's Laboratories Ltd, Joint Venture 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Dr. Reddy's Laboratories Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand